Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease

Detalles Bibliográficos
Autores principales: Kupryś-Lipińska, Izabela, Pałczyński, Cezary, Molinska, Joanna, Kuna, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627253/
https://www.ncbi.nlm.nih.gov/pubmed/31320863
http://dx.doi.org/10.5114/ada.2018.73140
_version_ 1783434695031128064
author Kupryś-Lipińska, Izabela
Pałczyński, Cezary
Molinska, Joanna
Kuna, Piotr
author_facet Kupryś-Lipińska, Izabela
Pałczyński, Cezary
Molinska, Joanna
Kuna, Piotr
author_sort Kupryś-Lipińska, Izabela
collection PubMed
description
format Online
Article
Text
id pubmed-6627253
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-66272532019-07-18 Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease Kupryś-Lipińska, Izabela Pałczyński, Cezary Molinska, Joanna Kuna, Piotr Postepy Dermatol Alergol Letter to the Editor Termedia Publishing House 2018-02-02 2019-04 /pmc/articles/PMC6627253/ /pubmed/31320863 http://dx.doi.org/10.5114/ada.2018.73140 Text en Copyright: © 2019 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Kupryś-Lipińska, Izabela
Pałczyński, Cezary
Molinska, Joanna
Kuna, Piotr
Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title_full Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title_fullStr Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title_full_unstemmed Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title_short Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
title_sort omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627253/
https://www.ncbi.nlm.nih.gov/pubmed/31320863
http://dx.doi.org/10.5114/ada.2018.73140
work_keys_str_mv AT kupryslipinskaizabela omalizumabtherapyinapatientwithsevereasthmaandcoexistingchronicobstructivepulmonarydisease
AT pałczynskicezary omalizumabtherapyinapatientwithsevereasthmaandcoexistingchronicobstructivepulmonarydisease
AT molinskajoanna omalizumabtherapyinapatientwithsevereasthmaandcoexistingchronicobstructivepulmonarydisease
AT kunapiotr omalizumabtherapyinapatientwithsevereasthmaandcoexistingchronicobstructivepulmonarydisease

Ejemplares similares